Pharmacogenetics for off-patent antipsychotics: reframing the risk for tardive dyskinesia and access to essential medicines.
about
Candidate gene-based association study of antipsychotic-induced movement disorders in long-stay psychiatric patients: a prospective studyEthical and Policy Considerations in the Application of Pharmacogenomic Testing for Tardive Dyskinesia: Case Study of the Dopamine D3 Receptor.Shifting emphasis from pharmacogenomics to theragnostics.Therapeutic drug monitoring of nortriptyline in smoking cessation: a multistudy analysis.Antipsychotic-induced tardive dyskinesia and polymorphic variations in COMT, DRD2, CYP1A2 and MnSOD genes: a meta-analysis of pharmacogenetic interactions.Physiogenomic comparison of weight profiles of olanzapine- and risperidone-treated patients.A common variant in DRD3 gene is associated with risperidone-induced extrapyramidal symptoms.
P2860
Q28729947-4F8BF9A8-FC05-4944-A545-AE98C91F6289Q35693061-36E470B0-12EB-43F4-AA7F-208B9665B292Q36561637-68DD2E4E-5ACE-4B05-A6EE-42438EAA5366Q37236959-7389E3D1-CC98-4549-B054-9001AA791606Q40136199-F46A1155-7F30-4FE5-A23C-F69DD8C5D710Q40255006-FA97C056-DB90-4800-A6B2-65FC1FB9BD11Q45977566-8E41CD68-03AB-4766-978A-2C3447D5D628
P2860
Pharmacogenetics for off-patent antipsychotics: reframing the risk for tardive dyskinesia and access to essential medicines.
description
2006 nî lūn-bûn
@nan
2006 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Pharmacogenetics for off-paten ...... access to essential medicines.
@ast
Pharmacogenetics for off-paten ...... access to essential medicines.
@en
type
label
Pharmacogenetics for off-paten ...... access to essential medicines.
@ast
Pharmacogenetics for off-paten ...... access to essential medicines.
@en
prefLabel
Pharmacogenetics for off-paten ...... access to essential medicines.
@ast
Pharmacogenetics for off-paten ...... access to essential medicines.
@en
P2093
P2860
P50
P356
P1476
Pharmacogenetics for off-paten ...... access to essential medicines.
@en
P2093
Christopher Reist
James B Lohr
Janice E Graham
Lawrence J Albers
Michael Caligiuri
Steven Mee
P2860
P304
P356
10.1517/14656566.7.2.119
P407
P577
2006-02-01T00:00:00Z